GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Johnson & Johnson (NEOE:JNJ) » Definitions » Cyclically Adjusted Book per Share

Johnson & Johnson (NEOE:JNJ) Cyclically Adjusted Book per Share : C$4.13 (As of Mar. 2025)


View and export this data going back to 2023. Start your Free Trial

What is Johnson & Johnson Cyclically Adjusted Book per Share?

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted Book per Share and the Cyclically Adjusted PB Ratio. The Cyclically Adjusted Book per Share is the average of the inflation adjusted Book Value per Share of a company over the past 10 years.

Johnson & Johnson's adjusted book value per share for the three months ended in Mar. 2025 was C$4.532. Add all the adjusted book value per share for the past 10 years together and divide the count will get our Cyclically Adjusted Book per Share, which is C$4.13 for the trailing ten years ended in Mar. 2025.

During the past 12 months, Johnson & Johnson's average Cyclically Adjusted Book Growth Rate was 0.90% per year. During the past 3 years, the average Cyclically Adjusted Book Growth Rate was 3.10% per year. During the past 5 years, the average Cyclically Adjusted Book Growth Rate was 4.00% per year. During the past 10 years, the average Cyclically Adjusted Book Growth Rate was 4.30% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the Cyclically Adjusted Book Growth Rate using Cyclically Adjusted Book per Share data.

During the past 13 years, the highest 3-Year average Cyclically Adjusted Book Growth Rate of Johnson & Johnson was 14.50% per year. The lowest was 2.70% per year. And the median was 10.90% per year.

As of today (2025-05-28), Johnson & Johnson's current stock price is C$20.19. Johnson & Johnson's Cyclically Adjusted Book per Share for the quarter that ended in Mar. 2025 was C$4.13. Johnson & Johnson's Cyclically Adjusted PB Ratio of today is 4.89.

During the past 13 years, the highest Cyclically Adjusted PB Ratio of Johnson & Johnson was 6.54. The lowest was 4.29. And the median was 5.35.


Johnson & Johnson Cyclically Adjusted Book per Share Historical Data

The historical data trend for Johnson & Johnson's Cyclically Adjusted Book per Share can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Johnson & Johnson Cyclically Adjusted Book per Share Chart

Johnson & Johnson Annual Data
Trend Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24
Cyclically Adjusted Book per Share
Get a 7-Day Free Trial Premium Member Only Premium Member Only - - - 4.13 4.09

Johnson & Johnson Quarterly Data
Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25
Cyclically Adjusted Book per Share Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 4.17 4.15 4.13 4.09 4.13

Competitive Comparison of Johnson & Johnson's Cyclically Adjusted Book per Share

For the Drug Manufacturers - General subindustry, Johnson & Johnson's Cyclically Adjusted PB Ratio, along with its competitors' market caps and Cyclically Adjusted PB Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Johnson & Johnson's Cyclically Adjusted PB Ratio Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Johnson & Johnson's Cyclically Adjusted PB Ratio distribution charts can be found below:

* The bar in red indicates where Johnson & Johnson's Cyclically Adjusted PB Ratio falls into.


;
;

Johnson & Johnson Cyclically Adjusted Book per Share Calculation

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted Book per Share and the Cyclically Adjusted PB Ratio. The Cyclically Adjusted Book per Share is the average of the inflation adjusted Book Value per Share of a company over the past 10 years.

What is Cyclically Adjusted Book per Share? How do we calculate Cyclically Adjusted Book per Share?

Cyclically Adjusted Book per Share is the average of the inflation adjusted Book Value per Share of a company over the past 10 years. Let's use an example to explain.

If we want to calculate the Cyclically Adjusted Book per Share of Wal-Mart (WMT) for Dec. 31, 2010, we need to have the inflation data and the book value per share from 2001 through 2010.

We adjusted the 2001 book value per share data with the total inflation from 2001 through 2010 to the equivalent book value in 2010. If the total inflation from 2001 to 2010 is 40%, and Wal-Mart's book value is $1 a share in 2001, then the 2001's equivalent book value in 2010 is $1.4 a share. If Wal-Mart's book value is $1 again in 2002, and the total inflation from 2002 through 2010 is 35%, then the equivalent 2002 book value in 2010 is $1.35. So on and so forth, you get the equivalent book value per share of past 10 years. Then you add them together and divided the sum by the count to get Cyclically Adjusted Book per Share.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.

For example, Johnson & Johnson's adjusted Book Value per Share data for the three months ended in Mar. 2025 was:

Adj_Book= Book Value per Share /CPI of Mar. 2025 (Change)*Current CPI (Mar. 2025)
=4.532/134.9266*134.9266
=4.532

Current CPI (Mar. 2025) = 134.9266.

Johnson & Johnson Quarterly Data

Book Value per Share CPI Adj_Book
201506 3.088 100.684 4.138
201509 3.335 100.392 4.482
201512 3.443 99.792 4.655
201603 3.395 100.470 4.559
201606 3.318 101.688 4.403
201609 3.406 101.861 4.512
201612 3.374 101.863 4.469
201703 3.397 102.862 4.456
201706 3.462 103.349 4.520
201709 3.289 104.136 4.261
201712 2.784 104.011 3.611
201803 2.965 105.290 3.800
201806 2.992 106.317 3.797
201809 3.052 106.507 3.866
201812 2.932 105.998 3.732
201903 2.886 107.251 3.631
201906 2.972 108.070 3.711
201909 2.848 108.329 3.547
201912 2.892 108.420 3.599
202003 3.160 108.902 3.915
202006 3.152 108.767 3.910
202009 3.150 109.815 3.870
202012 2.993 109.897 3.675
202103 3.056 111.754 3.690
202106 3.141 114.631 3.697
202109 3.288 115.734 3.833
202112 3.504 117.630 4.019
202203 3.497 121.301 3.890
202206 3.615 125.017 3.902
202209 3.697 125.227 3.983
202212 3.881 125.222 4.182
202303 3.628 127.348 3.844
202306 3.736 128.729 3.916
202309 3.892 129.860 4.044
202312 3.726 129.419 3.885
202403 3.828 131.776 3.920
202406 3.960 132.554 4.031
202409 3.838 133.029 3.893
202412 4.114 133.157 4.169
202503 4.532 134.927 4.532

Add all the adjusted book value per share together and divide the count will get our Cyclically Adjusted Book per Share.


Johnson & Johnson  (NEOE:JNJ) Cyclically Adjusted Book per Share Explanation

If a company grows much fast than inflation, Cyclically Adjusted Book per Share may underestimate the company's equity. Cyclically Adjusted PB Ratio can seem to be too high even the actual PB Ratio is low.

For the Cyclically Adjusted PB Ratio, the book value of the past 10 years are inflation-adjusted and averaged. The result is used for P/B calculation. Since it looks at the average over the last 10 years, the Cyclically Adjusted PB Ratio is also called CAPB Ratio.

The Shiller PE Ratio was first used by professor Robert Shiller. He uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings per share of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted PB Ratio. The Cyclically Adjusted Book per Share is the average of the inflation adjusted book value per share of a company over the past 10 years.

Johnson & Johnson's Cyclically Adjusted PB Ratio of today is calculated as

Cyclically Adjusted PB Ratio=Share Price/Cyclically Adjusted Book per Share
=20.19/4.13
=4.89

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

During the past 13 years, the highest Cyclically Adjusted PB Ratio of Johnson & Johnson was 6.54. The lowest was 4.29. And the median was 5.35.


Be Aware

Cyclically Adjusted PB Ratio works better for cyclical companies. It gives you a better idea on the company's real book value.


Johnson & Johnson Cyclically Adjusted Book per Share Related Terms

Thank you for viewing the detailed overview of Johnson & Johnson's Cyclically Adjusted Book per Share provided by GuruFocus.com. Please click on the following links to see related term pages.


Johnson & Johnson Business Description

Industry
Address
One Johnson & Johnson Plaza, New Brunswick, NJ, USA, 08933
Johnson & Johnson is the world's largest and most diverse healthcare firm. It has two divisions: pharmaceutical and medical devices. These now represent all of the company's sales following the divestment of the consumer business, Kenvue, in 2023. The drug division focuses on the following therapeutic areas: immunology, oncology, neurology, pulmonary, cardiology, and metabolic diseases. Geographically, just over half of total revenue is generated in the United States.